Skip to content
Review Open access

Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk

Aug 2026 · Cell Biology International · Vol 50 · 0 citations · 69 references
Medicine

TL;DR

Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.

Abstract

Gastric cancer (GC) remains a leading cause of cancer‐related mortality, with chemoresistance posing a critical barrier to effective treatment. Tumor‐associated macrophages (TAMs), particularly the immunosuppressive M2‐polarized subset, are emerging as pivotal mediators of chemoresistance within the tumor microenvironment (TME). TAMs promote resistance through multifaceted mechanisms, including activation of pro‐survival signaling pathways, induction of epithelial–mesenchymal transition (EMT), and enhancement of angiogenesis. For instance, M2‐like TAMs secrete CXCL5, which activates the PI3K/AKT/mTOR axis in GC cells, thereby conferring resistance to 5‐fluorouracil (5‐FU). Similarly, TMEM, a transmembrane protein overexpressed in cisplatin‐resistant GC, drives M2 polarization of TAMs via the Wnt/β‐catenin pathway, further amplifying drug resistance and tumor progression. Clinical studies reveal that high TAM infiltration correlates with poor chemotherapy response and reduced survival in GC patients. This review synthesizes current evidence on TAM‐driven chemoresistance in GC, highlighting the molecular interplay between TAMs, tumor cells, and stromal components. It underscores the potential of TAM‐centric therapies—including checkpoint inhibitors, epigenetic modulators, and combination regimens—to overcome resistance and improve clinical outcomes. By integrating preclinical insights and clinical data, this work provides a roadmap for developing precision therapies that exploit TAM biology to enhance chemosensitivity in GC.

Read PDF

Similar papers

Review Open access Sep 2026

Tumor-associated macrophages in gastric cancer peritoneal metastasis: orchestrating immune evasion, niche remodeling, and therapeutic resistance

This Review focuses on the two major origins of peritoneal macrophages, and describes how gastric cancer cells exploit their plasticity by metabolic signals, exosomal oncomiRs, paracrine factors and so on to push them into a pro-metastatic phenotype.

Min Chen, Yu-Yang Li, Hui-Nan Wang et al. · 0 citations
Review Open access Sep 2026

The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials

Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastasis, therapeutic resistance, and an immunosuppressive TME representing major barriers to successful treatment. Among the chemokine signaling networks implicated in these processes, the CCL2–CCR2 axis has emerged as an important reg...

Yu-Jie Huang, Jia Ma, J. Bi et al. · 0 citations
Aug 2026

Targeting GEM Reprograms Macrophages and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.

GTP-binding protein overexpressed in skeletal muscle (GEM) is identified as a tumor cell-intrinsic regulator associated with poor response to anti-PD-L1 therapy in ESCC and a GEM-SERPINE1-LRP1 signaling axis that drives macrophage-mediated immune suppression is defined.

Lin-Feng Wu, C. Ren, Yi-Fei Zhang et al. · 0 citations
Review Sep 2026

Targeting lncRNA-regulated macrophage polarization: a novel therapeutic strategy for pancreatic ductal adenocarcinoma

Key lncRNAs involved in TAM polarization in PDAC are summarized, highlighting their roles in inducing the M2 phenotype and promoting PDAC progression through epigenetic modifications, ceRNA networks, and signal transduction pathways.

Hong-Shi Sun, Jia Wang, Zhong-Bo Xie et al. · 0 citations
Sep 2026

Targeting Tumor–CAFs Crosstalk to Reverse Drug Resistance and Immunosuppression Through Cuproptosis

Chemotherapy resistance and immunosuppression are the current key bottlenecks in tumor treatment. In the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) secrete dense extracellular matrix and various immunosuppressive factors, forming a dynamic “tumor–CAFs crosstalk”, which drives the progression o...

Qing-Qing Xu, Shuai-Peng Feng, Dong-Lin Bian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.